Inhibition of HDAC activity can alter SMC proliferation.16–19 Although there is some discrepancy, most in vivo studies show that HDAC inhibition suppresses neointimal lesion formation,18,20 which suggests a potential therapeutic target for cardiovascular diseases. The gene discussed is HDAC9; the disease is cardiovascular disorder.